Clinical trial NCT02656589 - References

Breast Cancer — microRNA of Human Epidermal Growth Factor Receptor 2 （HER2）Positive Patient Treated With Herceptin

Citation(s)

•   Chan M, Liaw CS, Ji SM, Tan HH, Wong CY, Thike AA, Tan PH, Ho GH, Lee AS
  Identification of circulating microRNA signatures for breast cancer detection. Clin Cancer Res. 2013 Aug 15;19(16):4477-87. doi: 10.1158/1078-0432.CCR-12-3401. Epub 2013 Jun 24.
•   Gururajan M, Josson S, Chu GC, Lu CL, Lu YT, Haga CL, Zhau HE, Liu C, Lichterman J, Duan P, Posadas EM, Chung LW
  miR-154* and miR-379 in the DLK1-DIO3 microRNA mega-cluster regulate epithelial to mesenchymal transition and bone metastasis of prostate can
•   Hur K, Toiyama Y, Schetter AJ, Okugawa Y, Harris CC, Boland CR, Goel A
  Identification of a metastasis-specific MicroRNA signature in human colorectal cancer. J Natl Cancer Inst. 2015 Feb 6;107(3). pii: dju492. doi: 10.1093/jnci/dju492. Print 2015 Mar.
•   Jackson DB
  Serum-based microRNAs: are we blinded by potential? Proc Natl Acad Sci U S A. 2009 Jan 6;106(1):E5. doi: 10.1073/pnas.0809999106. Epub 2008 Dec 23.
•   Jiang L, Cheng Q, Zhang BH, Zhang MZ
  Circulating microRNAs as biomarkers in hepatocellular carcinoma screening: a validation set from China. Medicine (Baltimore). 2015 Mar;94(10):e603. doi: 10.1097/MD.0000000000000603.
•   Kleivi Sahlberg K, Bottai G, Naume B, Burwinkel B, Calin GA, Børresen-Dale AL, Santarpia L
  A serum microRNA signature predicts tumor relapse and survival in triple-negative breast cancer patients. Clin Cancer Res. 2015 Mar 1;21(5):1207-14. doi: 10.1158/1
•   Li A, Yu J, Kim H, Wolfgang CL, Canto MI, Hruban RH, Goggins M
  Serum miR-1290 as a marker of pancreatic cancer--response. Clin Cancer Res. 2013 Sep 15;19(18):5252-3. doi: 10.1158/1078-0432.CCR-13-1899. Epub 2013 Jul 23.
•   Li J, Wang Y, Yu W, Chen J, Luo J
  Expression of serum miR-221 in human hepatocellular carcinoma and its prognostic significance. Biochem Biophys Res Commun. 2011 Mar 4;406(1):70-3. doi: 10.1016/j.bbrc.2011.01.111. Epub 2011 Feb 3.
•   Li LM, Hu ZB, Zhou ZX, Chen X, Liu FY, Zhang JF, Shen HB, Zhang CY, Zen K
  Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma. Cancer Res. 2010 Dec 1;70(23):9798-807. doi: 10.1158/0008-5472.CA
•   Masuda S, Izpisua Belmonte JC
  Re: Serum miR-21 as a diagnostic and prognostic biomarker in colorectal cancer. J Natl Cancer Inst. 2014 Mar;106(3):djt457. doi: 10.1093/jnci/djt457. Epub 2014 Mar 1.
•   Parpart S, Roessler S, Dong F, Rao V, Takai A, Ji J, Qin LX, Ye QH, Jia HL, Tang ZY, Wang XW
  Modulation of miR-29 expression by a-fetoprotein is linked to the hepatocellular carcinoma epigenome. Hepatology. 2014 Sep;60(3):872-83. doi: 10.1002/hep.27200.
•   Roth C, Rack B, Müller V, Janni W, Pantel K, Schwarzenbach H
  Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer. Breast Cancer Res. 2010;12(6):R90. doi: 10.1186/bcr2766. Epub 2010 Nov 3.
•   Schwarzenbach H, Nishida N, Calin GA, Pantel K
  Clinical relevance of circulating cell-free microRNAs in cancer. Nat Rev Clin Oncol. 2014 Mar;11(3):145-56. doi: 10.1038/nrclinonc.2014.5. Epub 2014 Feb 4. Review.
•   van Schooneveld E, Wouters MC, Van der Auwera I, Peeters DJ, Wildiers H, Van Dam PA, Vergote I, Vermeulen PB, Dirix LY, Van Laere SJ
  Expression profiling of cancerous and normal breast tissues identifies microRNAs that are differentially expressed in ser
•   Wang Y, Gu J, Roth JA, Hildebrandt MA, Lippman SM, Ye Y, Minna JD, Wu X
  Pathway-based serum microRNA profiling and survival in patients with advanced stage non-small cell lung cancer. Cancer Res. 2013 Aug 1;73(15):4801-9. doi: 10.1158/0008-5472.CAN-12-32
•   Xiang M, Zeng Y, Yang R, Xu H, Chen Z, Zhong J, Xie H, Xu Y, Zeng X
  U6 is not a suitable endogenous control for the quantification of circulating microRNAs. Biochem Biophys Res Commun. 2014 Nov 7;454(1):210-4. doi: 10.1016/j.bbrc.2014.10.064. Epub 2014 O
•   Zhai R, Wei Y, Su L, Liu G, Kulke MH, Wain JC, Christiani DC
  Whole-miRNome profiling identifies prognostic serum miRNAs in esophageal adenocarcinoma: the influence of Helicobacter pylori infection status. Carcinogenesis. 2015 Jan;36(1):87-93. doi: 10.109

A Perspective Study of the Predictive Value of microRNA in Patients With HER2 Positive Advanced Stage Breast Cancer Who Were Treated With Herceptin

Details for clinical trial NCT02656589